Opioids are used to treat chronic as well as acute pain among the patients. Side-effects associated with opioid administration are dizziness, sedation, vomiting, nausea, physical dependence, constipation, tolerance, and respiratory depression. Antihistamines, antipsychotics and other types of drugs are used to reduce the side effects of opioids
MARKET DYNAMICS
The key factors driving the growth of the opioid induced side effects treatment market are increasing prevalence of chronic diseases like cancer, postsurgical pain, arthritis and others, increasing prescription of opioids, and advanced healthcare infrastructure. However, deaths due to drug over dose is likely to hamper the growth of the market.
MARKET SCOPE
The "Opioid Induced Side Effects Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of opioid induced side effects treatment market with detailed market segmentation by product type, application, and distribution channel. The opioid induced side effects treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Opioid Induced Side Effects Treatment market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The opioid induced side effects treatment market is segmented on the basis of product type, application, and distribution channel. Based on product type, the market is segmented antihistamines, antipsychotics, prokinetic agents, central nervous system (CNS) stimulant, laxative, and other. Based on application the market is segmented into drug overdose treatment, pain treatment, and other. The distribution channel market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Opioid Induced Side Effects Treatment market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Opioid Induced Side Effects Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Opioid Induced Side Effects Treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Opioid Induced Side Effects Treatment market in these regions.
MARKET PLAYERS
The report covers key developments in the Opioid Induced Side Effects Treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Opioid Induced Side Effects Treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for Opioid Induced Side Effects Treatment in the global market. Below mentioned is the list of few companies engaged in the Opioid Induced Side Effects Treatment market.
The report also includes the profiles of key players in Opioid Induced Side Effects Treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Astrazeneca PLC
- S.L.A. Pharma AG
- Shionogi And CO., LTD.
- Cubist Pharmaceuticals, Inc
- Progenics Pharmaceuticals, Inc
- Aiko Biotechnology, Inc
- Theravance Biopharma Inc
- Valeant Pharmaceuticals International
- Cosmo Pharmaceuticals S.A
- Merck and Co. Inc
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.